Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)

Clinical trial NCT00067808 · COMPLETED

Trial details

NCT number: NCT00067808
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia

Start date: 2003-10-01
Primary completion: 2009-05-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.